High Dose Therapy for Influenza Drug ICAAC 2013
59 views · Published 22 February 2016 · 20:50 · Indexed 27 October 2026
Channel: ASM - Microbes Make Our World · 2016 · Science & Technology
Critically ill patients with the pandemic H1N1 influenza who received triple the standard dose of the influenza drug oseltamivir were 7 times more likely to completely clear the virus from their system in 5 days than those who received the standard dose. This discussion will address the healthcare implications of these findings, including a rationale for high dose therapy of sensitive strains of influenza. Anand Kumar, Hlth. Sci. Ctr., Winnipeg, MB, Canada
More from this channel
-
4:18
Curbing Climate Change with Algae - Cultures Digital Feature
-
29:36
An Epidemiological Survey of Toothbrush Contamination in Communal Bathrooms - ASM Live 2015
-
29:28
The Effect of Agion Silver Technology on the Bacterial Populations Found on Door Handles
-
26:25
Antibiotic Stewardship: Saving Drugs, Saving Money - ICAAC 2014
-
30:17
Co-contribution of rotavirus and pneumococcal vaccines in reduction of pediatric hospital burden
-
27:12
Bordetella parapertussis Outbreak in Southeastern Minnesota in 2014 - ICAAC 2015
-
25:57
New Targets for SARS/MERS Drugs - ICAAC 2014
-
41:26
Emerging Answers from the Ebola Outbreak - ICAAC 2014